Ptc Therapeutics reported $-127208000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Biogen BIIB:US USD 821M 53.8M
Bluebird Bio BLUE:US USD -76513000 16.99M
Cytokinetics CYTK:US USD -142310000 122.49M
Daiichi Sankyo 4568:JP JPY 61.85B 32.44B
Enanta Pharmaceuticals ENTA:US USD -26334000 5.81M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Karyopharm Therapeutics KPTI:US USD -36279000 12.66M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Tg Therapeutics TGTX:US USD -35818000 4.69M
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
Xencor XNCR:US USD -31671000 2.3M
YTE INCY:US USD 178.22M 131.36M